Simplex Trading
OTLK icon

Simplex Trading’s Outlook Therapeutics OTLK Stock Holding History

Simplex Trading’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
103,500
+101,800
+5,988% +$63.1K ﹤0.01% 4957
2026
Q1 		$349 Sell
1,700
-6,600
-80% -$2.85K ﹤0.01% 8777
2025
Q4 		$13.1K Buy
+8,300
New +$13.3K ﹤0.01% 6811
2025
Q1 		– Sell
-2,000
Closed -$3K – 9344
2024
Q4 		$3K Sell
2,000
-2,100
-51% -$8.64K ﹤0.01% 7905
2024
Q3 		$21K Buy
4,100
+3,100
+310% +$22.7K ﹤0.01% 6646
2024
Q2 		$7K Buy
+1,000
New +$8.03K ﹤0.01% 7690

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Simplex Trading's OTLK Position: Q2 2026 in Review

Simplex Trading increased its Outlook Therapeutics (OTLK) stake by 55% in Q2 2026, buying an estimated $44.9K and bringing the position to 205,013 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #4128.

Simplex Trading first reported a position in OTLK in Q2 2024 and has held it in 5 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Simplex Trading held 205,013 shares of Outlook Therapeutics worth $326K as of Q2 2026.
  • Simplex Trading bought 72,347 Outlook Therapeutics shares in Q2 2026, an estimated $44.9K.
  • Outlook Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4128 holding.
  • Simplex Trading first reported a position in Outlook Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.